Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Akanda's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Akanda (AKAN) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2025
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
Share of combined sales, Q4 2025
Revenue Growth Y/Y
-
Q4 2025
Net Margin
-17,690.19 %
Q4 2025

Key Findings: Akanda vs Its Competitors

  • TTM: Trailing 12-month revenue of 0M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
  • Scale: Akanda ranks #23 of 36 companies by market capitalization in the Legal Cannabis industry, holding 0.0% of industry market cap.
  • Peer revenue share: Akanda accounted for 100.0% of combined revenue among its tracked peer group.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

AKAN Sales vs. its Competitors, Q4 2025

Akanda generated 100.00 % of the combined sales of its peer group.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/AKAN/competitors
https://api.csimarket.com/api/v1/companies/AKAN/relationships
https://api.csimarket.com/api/v1/companies/AKAN/similar
Programmatic access for models, analytics, and integration workflows.

Akanda's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Akanda Corp - No No Yes
High-Confidence Competitors (8) 14% 63% 63% 13%
Similar-Size Competitors (5) 0% 50% 50% 60%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2025

100%market share
  • Akanda100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Akanda and its 0 tracked competitors.

See Akanda's full market share breakdown »

AKAN Stock Performance relative to its Competitors

AKAN Competitors (weighted) Percent change over the selected range

Akanda's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
High-Confidence
(0 of 4)
0%beat U.S.A. 500
Similar-Size
(0 of 2)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Akanda Corp -97.90 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (4) 40.4% 63.2%
Similar-Size Competitors (2) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Akanda's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

AKAN Stock Performance relative to High-Confidence Competitors

AKAN High-Confidence Competitors (equal-weighted, 10) Percent change over the selected range

AKAN Stock Performance relative to Similar-Size Competitors

AKAN Similar-Size Competitors (equal-weighted, 5) Percent change over the selected range

Akanda's Comment on Competition and Industry Peers

The company operates in competitive markets including the Canadian hemp and cannabis industries, as well as telecommunications infrastructure. In the CBD segment of the cannabis industry, competitors include Charlotte’s Web, Cresco Labs, and the Valens Company. In the THC segment, competitors include Aurora Cannabis, Canopy Growth, Aphria, CannTrust Holdings, and Aleafia Health. Within telecommunications infrastructure, companies developing telecommunication towers include Centennial Towers, QMC, Torrecom, MX Towers, MTP, and American Tower. Competitors in the fiber optic network sector include Neutral Networks, Summit1G, National Fiber Networks, Fermaca Networks, and ICOM Construcciones.

Akanda's Competitors Named by the Company

Competitive relationships identified from Akanda reports and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Cresco Labs Company report 85% 2022 to 2026 3
MX Towers Company report 85% 2022 to 2026 3
Aleafia Health Company report 85% 2022 to 2026 3
Charlotte’s Web Company report 85% 2022 to 2026 3
Aphria Company report 85% 2022 to 2026 3
Canopy Growth Company report 85% 2022 to 2026 3
Fermaca Networks Company report 85% 2022 to 2026 3
National Fiber Networks Company report 85% 2022 to 2026 3
Torrecom Company report 85% 2022 to 2026 3
MTP Company report 85% 2022 to 2026 3
QMC Company report 85% 2022 to 2026 3
the Valens Company Company report 85% 2022 to 2026 3
Aurora Cannabis Company report 85% 2022 to 2026 3
Centennial Towers Company report 85% 2022 to 2026 3
ICOM Construcciones Company report 85% 2022 to 2026 3
Neutral Networks Company report 85% 2022 to 2026 3
Summit1G Company report 85% 2022 to 2026 3
American Tower Company report 85% 2022 to 2026 3
CannTrust Holdings Company report 85% 2022 to 2026 3
Tilray Portugal, Unipessoal, Lda Company report 85% 2022 to 2026 3
Portocanna SA Company report 85% 2022 to 2026 3
The Lyphe Group Company report 85% 2022 to 2026 3
WeedMD Company report 85% 2022 to 2026 3
48 North Company report 85% 2022 to 2026 3
Aleafia Health/ Red White and Bloom Company report 85% 2022 to 2026 3
Clever Leaves Portugal Unipessoal Lda Company report 85% 2022 to 2026 3
Agrivab Medical Cannabis Company report 85% 2022 to 2026 3
RPK Company report 85% 2022 to 2026 3
Canmart Company report 85% 2022 to 2026 3
Bedrocan Company report 85% 2022 to 2026 3
Medigrow Company report 85% 2022 to 2026 3
Spectrum Cannabis Company report 85% 2022 to 2026 3
Verve Dynamics Company report 85% 2022 to 2026 3
Competitor Evidence Detail

Company report basis, confidence, active dates and source counts for Akanda's named competitors require a Commercial License.

Methodology: relationships are extracted from Akanda reports (named-competitor disclosures) and corroborating sources. Confidence reflects evidence strength.

Get the full CSIMarket dataset: Subscribe API Connect Your AI